4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0001923794-26-000002
Chief Technology Officer sold 7,000 shares at $10.02 ($70,151)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tyagarajan Seshu Chief Technology Officer | 2026-06-29 | Sale 10b5-1 | −7,000 | $10.02 | $70,151 | 83,865 | D |
| Open-market sales · 7,000 sh · avg $10.02 · $70,151 | |||||||
Loading xslF345X06/ownership.xml…